Davies EH, Seunarine KK, Banks T, Clark CA, Vellodi A. Brain white matter abnormalities in paediatric Gaucher Type I and Type III using diffusion tensor imaging.
J Inherit Metab Dis. 2011 Feb 12.
Davies EH, Ollivier CM, Saint Raymond A. Paediatric investigation plans for pain: painfully slow!
Eur J Clin Pharmacol. 2010 Nov;66(11):1091-7.
Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, Mengel E, Erikson A, Schiffmann R;
Management of neuronopathic Gaucher disease: revised recommendations. European Working Group on Gaucher Disease.
J Inherit Metab Dis. 2009 Oct;32(5):660-4.
Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik IN, Benko W, Timmons M, Ries M, Vellodi A.
Randomized, controlled trial of miglustat in Gaucher's disease type 3.
Ann Neurol. 2008 Nov;64(5):514-22.
Davies EH, Tuleu C.
Medicines for children: a matter of taste.
J Pediatr. 2008 Nov;153(5):599-604
The selection and use of essential medicines.WHO Expert Committee.
World Health Organ Tech Rep Ser. 2008;(950):backcover, vii-174.
Davies EH, Erikson A, Collin-Histed T, Mengel E, Tylki-Szymanska A, Vellodi A.
Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases.
J Inherit Metab Dis. 2007 Nov;30(6):935-42.
Davies EH, Surtees R, DeVile C, Schoon I, Vellodi A.
A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease.
J Inherit Metab Dis. 2007 Oct;30(5):768-82.
Davies EH, Molloy A
Comparison of ethyl chloride spray with topical anaesthetic in children experiencing venepuncture.
Paediatr Nurs. 2006 Apr;18(3):39-43.